Daniel Bauer

Daniel Bauer is an Associate Director at Poseida Therapeutics, Inc., where they focus on clinical biomarkers. They have previously held positions as a Senior Scientist at Bristol Myers Squibb and as a Scientist at Vesta Therapeutics, Inc. In their earlier career, Daniel worked as a Research Associate at the University of Houston and MIT. Daniel also gained valuable experience through internships at Biogen and Eli Lilly. They are currently pursuing degrees in Biochemistry and Environmental Studies from Bowdoin College, as well as Toxicology from the University of North Carolina at Chapel Hill.